Latest Articles

Dr. Jennifer Mann, associate director of Science at UK Biocentre, explains why a blind spot in current direct-to-consumer genetic testing practices requires closer analysis and change.

We spoke with Dr. Niranjan Bose, managing director, Health & Life Sciences Strategy, Gates Ventures, about how proteomics-based biomarkers and international partnerships are changing the future of neurodegenerative disease research.

Discover how ABC transporters could offer a targeted approach to tackle drug-resistant bacteria and combat antimicrobial resistance.

This article explores how mass spectrometry and emerging analytical techniques are helping researchers decode the aging proteome at multiple scales – from plasma to specific tissues to individual organelles.

Researchers are investigating blood-based biomarkers like pTau217 for Alzheimer’s detection, offering a less invasive alternative to traditional methods. However, challenges remain due to the interference of proteins from other organs.

Learn how specific miRNA signatures have potential as metastatic colorectal cancer biomarkers, enhancing non-invasive detection and patient risk stratification.

Learn about the potential of EEG biomarkers in the early detection and monitoring of neurological diseases such as Alzheimer's with Dr. Javier Escudero, reader in biomedical signal processing at the University of Edinburgh.

Experts discuss how academic publishing must change to support open science, transparency and global accessibility in a digital-first research world.

Discover what glycan analysis can reveal about protein behavior and how it can be used to boost biologic performance and ensure therapeutic quality in biopharmaceutical drug development.

By improving sensitivity and boosting signal amplification, nanomaterials are heralding a new era for biomarker detection.